Table 1.
Inclusion criteria | Exclusion criteria |
1. ≥18 years of age | 1. Atypical parkinsonian syndromes |
2. ≥21 on the Montreal Cognitive Assessment53 | 2. For using the GrindCare: pacemaker |
3. Fulfil clinical diagnostic criteria for PD54 | 3. For using the BruxApp: no smartphone |
4. For the DAT-SPECT: no deep brain stimulation implant present |
When patients have a pacemaker, they cannot use the GrindCare GC4 (ie, a portable, single-channel electromyographic recorder to detect sleep bruxism) and will be excluded from that specific part of the study. When patients do not have a smartphone, participants cannot use the BruxApp (ie, an application on a smartphone to assess awake bruxism) and will be excluded from that specific part of the study.
DAT-SPECT, dopamine transporter single photon emission CT; PD, Parkinson’s disease.